0001209191-23-030794.txt : 20230518 0001209191-23-030794.hdr.sgml : 20230518 20230518183037 ACCESSION NUMBER: 0001209191-23-030794 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230516 FILED AS OF DATE: 20230518 DATE AS OF CHANGE: 20230518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACARTNEY LAWSON CENTRAL INDEX KEY: 0001606831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 23937455 MAIL ADDRESS: STREET 1: C/O AMBRX, INC. STREET 2: 10975 N. TORREY PINES RD. CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-16 0 0001607678 Viking Therapeutics, Inc. VKTX 0001606831 MACARTNEY LAWSON C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 1 0 0 0 0 Common Stock, par value $0.00001 per share 2023-05-16 4 M 0 16000 1.19 A 63965 D Common Stock, par value $0.00001 per share 2023-05-16 4 S 0 16000 24.00 D 47965 D Stock Option (Right to Buy) 1.19 2023-05-16 4 M 0 16000 0.00 D 2018-01-03 2027-01-03 Common Stock 16000 0 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. /s/ Michael Morneau as Attorney-in-Fact 2023-05-18